Journey Medical Corporation (DERM) Financials
DERM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 65.9 million | 48.5 million |
2023-06-30 | 69.7 million | 69.7 million |
2023-03-31 | 95.9 million | 88.4 million |
2022-12-31 | 105.2 million | 88.2 million |
DERM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 18.7 million | 558000 |
2023-06-30 | 4.0 million | 873000 |
2023-03-31 | -6.0 million | 646000 |
2022-12-31 | -23.8 million | 1.4 million |
DERM Net Income
No data available :(
DERM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 24.7 million | - | 131000 |
2023-06-30 | 8.2 million | - | 154000 |
2023-03-31 | 17.3 million | - | 177000 |
2022-12-31 | 32.0 million | - | 191000 |
DERM Shares Outstanding
DERM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 2.2 million | 8.6 million | - |
2023-06-30 | - | 1.8 million | 12.1 million | - |
2023-03-31 | 5.0 million | 2.0 million | 13.3 million | - |
2022-12-31 | 20.0 million | 4.3 million | 14.0 million | - |
DERM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 34.5 million | 6.4 million |
2023-06-30 | 17.2 million | 7.8 million |
2023-03-31 | 12.2 million | 6.4 million |
2022-12-31 | 16.0 million | 7.7 million |
DERM
Price: $3.69
52 week price:
Earnings Per Share: -0.69 USD
P/E Ratio: -6.99
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 25200
Ebitda: -176.2 millionMarket Capitalization: 83.3 million